Enlightening disease

Exploring the potential of advanced therapies through allogeneic cells

Our pipeline is focused on unlocking the potential of advanced cellular therapies through allogeneic cells, by exploring investigational approaches for clinical areas with limited therapeutic options. We focus on the use of mesenchymal stem cells for regenerative tissue in dermatology. In addition, we are involved in external programs focused on inmune restoration using allogeneic cells, offering a scalable manufacturing infraestructure compliant with current European regulatory standards.